30.40
10-January-25 15:45:00
15 minutes delayed
Stocks
+0.17
+0.56%
Today's range
29.19 - 30.56
ISIN
N/A
Source
NASDAQ
Immunocore Announces Upcoming Presentations at the American Association for Cancer Research (AACR) 2021 Annual Meeting
10 Mar 2021 18:00:00 By Nasdaq GlobeNewswire
Immunocore’s tebentafusp granted Breakthrough Therapy Designation for unresectable or metastatic uveal melanoma from FDA
19 Feb 2021 06:00:00 By Nasdaq GlobeNewswire